Andréanne Lupien, McGill University

Research

Acceptability Adaptive Trial Cost-Effectiveness Multi-Arm Trial Multicentre Trial Randomized Trial Safety Tolerability

Latest funding

Resensitizing bacteria to itaconate as a new approach for the treatment of infections
CIHR · 2026 · Co-investigator
$860,626
Finding the right balance: An adaptive trial to identify the safest regimen with the shortest duration for TB prevention (treatment of TB Infection)
CIHR · 2023 · Principal investigator
$1,154,425
Finding the right balance: An adaptive trial to identify the safest regimen with the shortest duration for TB prevention (treatment of TB Infection)
CIHR · 2023 · Principal investigator
$4,617,694

Resensitizing bacteria to itaconate as a new approach for the treatment of infections

Co-investigatorCIHR2026Project Grant

Principal investigators: Auclair, Karine

Keywords: Antibacterials; In Vitro Antibacterial Studies; In Vivo Antibacterial Studies; Medicinal Chemistry; Pharmacokinetic Studies

$860,626

Finding the right balance: An adaptive trial to identify the safest regimen with the shortest duration for TB prevention (treatment of TB Infection)

Principal investigatorCIHR2023Operating Grant: Clinical Trials Projects - Indirect Costs

Principal investigators: Menzies, Richard; Campbell, Jonathon; Fox, Gregory; Golchi, Shirin; Johnston, James C; Law, Stephanie; Long, Richard; Lupien, Andréanne; Ruslami, Rovina

Keywords: Acceptability; Adaptive Trial; Cost-Effectiveness; Multi-Arm Trial; Multicentre Trial; Randomized Trial; Safety; Tolerability; Tuberculosis; Tuberculosis Prevention

$1,154,425

Finding the right balance: An adaptive trial to identify the safest regimen with the shortest duration for TB prevention (treatment of TB Infection)

Principal investigatorCIHR2023Operating Grant: Clinical Trials Projects

Principal investigators: Menzies, Richard; Campbell, Jonathon; Fox, Gregory; Golchi, Shirin; Johnston, James C; Law, Stephanie; Long, Richard; Lupien, Andréanne; Ruslami, Rovina

Keywords: Acceptability; Adaptive Trial; Cost-Effectiveness; Multi-Arm Trial; Multicentre Trial; Randomized Trial; Safety; Tolerability; Tuberculosis; Tuberculosis Prevention

$4,617,694

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Mention their CIHR grant from 2023

Subject: Prospective PhD student: Acceptability Dear Professor Lupien, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. Your research on acceptability connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Finding the right balance: An adaptive trial to identify the safest regimen with the shortest duration for TB prevention (treatment of TB Infection)" (2023), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]